Not applicableStudy completedNCT04015102What this trial is testingA Registry for Hereditary Cancer Risk Assessment and Genetic TestingWho this might be right forProstate Cancer Myriad Genetic Laboratories, Inc. 255
Large-scale testing (Phase 3)Study completedNCT02294461What this trial is testingAn Asian Study to Evaluate Efficacy and Safety of Oral Enzalutamide in Progressive Metastatic Prostate Cancer ParticipantsWho this might be right forProgressive Metastatic Prostate Cancer Astellas Pharma Inc 395
Early research (Phase 1)Ended earlyNCT05673109What this trial is testingAC176 for the Treatment of Metastatic Castration Resistant Prostate CancerWho this might be right forMetastatic Castration Resistant Prostate Cancer Accutar Biotechnology Inc 8
Not applicableStudy completedNCT07416812What this trial is testingTargeted Prostate Cancer Screening in Men With BRCA1/2 MutationsWho this might be right forProstate CancerHereditary Prostate Cancer Institute of Oncology Ljubljana 25
Testing effectiveness (Phase 2)Ended earlyNCT02203513What this trial is testingA Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate CancerWho this might be right forOvarian CancerBreast CancerProstate Cancer National Cancer Institute (NCI) 111
Not applicableStudy completedNCT00001469What this trial is testingGenetic Analysis of Hereditary Prostate CancerWho this might be right forProstate Cancer National Human Genome Research Institute (NHGRI) 7,776
Not applicableUnknownNCT00959023What this trial is testingStudy of Blood and Tumor Samples From Men With an Inherited Risk of Prostate CancerWho this might be right forProstate Cancer Institute of Cancer Research, United Kingdom 21,000
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Not applicableActive Not RecruitingNCT05696444What this trial is testingMedtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO)Who this might be right forBladder CancerProstate CancerKidney Cancer+6 more Medtronic - MITG 144
Early research (Phase 1)Study completedNCT00892736What this trial is testingVeliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous TherapyWho this might be right forBasal-Like Breast CarcinomaBRCA1 Mutation CarrierBRCA2 Mutation Carrier+14 more National Cancer Institute (NCI) 98
Early research (Phase 1)Study completedNCT01155258What this trial is testingTemsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid TumorsWho this might be right forExtensive Stage Small Cell Lung CancerHereditary ParagangliomaMale Breast Cancer+45 more University of Southern California 19
Testing effectiveness (Phase 2)Looking for participantsNCT07292168What this trial is testingA Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Expressing Fibroblast Growth Factor Receptor 1Who this might be right forRenal Cell Carcinoma MetastaticProstate Cancer MetastaticNon-small Cell Lung Cancer Metastatic+2 more Kidney Cancer Research Bureau 58
Not applicableLooking for participantsNCT03805919What this trial is testingMen at High Genetic Risk for Prostate CancerWho this might be right forProstatic Neoplasms National Cancer Institute (NCI) 500
Testing effectiveness (Phase 2)Active Not RecruitingNCT04090528What this trial is testingPTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate CancerWho this might be right forCastration-resistant Prostate CancerMetastatic CancerProstate Cancer University of Wisconsin, Madison 60
Not applicableLooking for participantsNCT05129605What this trial is testingProstate Cancer Genetic Risk Evaluation and Screening StudyWho this might be right forProstatic NeoplasmProstate CancerBRCA2 Mutation+5 more Massachusetts General Hospital 400
Not applicableLooking for participantsNCT02012699What this trial is testingIntegrated Cancer Repository for Cancer ResearchWho this might be right forPancreatic CancerThyroid CancerLung Cancer+47 more University of Nebraska 999,999
Not applicableLooking for participantsNCT04052048What this trial is testingActive Surveillance SNEP Assay Registry Trial for Prostate CancerWho this might be right forProstate Cancer Aggressiveness Immunis.AI 2,000
Early research (Phase 1)Temporarily pausedNCT01337518What this trial is testingA Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate CancerWho this might be right forProstatic Neoplasm Enzon Pharmaceuticals, Inc. 150
Testing effectiveness (Phase 2)Looking for participantsNCT07190300What this trial is testingTulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)Who this might be right forMetastatic Hormone-Sensitive Prostate Cancer (mHSPC) Novartis Pharmaceuticals 181
Testing effectiveness (Phase 2)Study completedNCT04564027What this trial is testingA Study Investigating DNA-damage Response Agents in Molecularly Altered Advanced CancerWho this might be right forAdvanced Solid Tumours AstraZeneca 54